LG H&H Co., Ltd.

KOSE:A051900 Stock Report

Market Cap: ₩5.2t

LG H&H Valuation

Is A051900 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A051900 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A051900 (₩321500) is trading below our estimate of fair value (₩616925.77)

Significantly Below Fair Value: A051900 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A051900?

Key metric: As A051900 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for A051900. This is calculated by dividing A051900's market cap by their current earnings.
What is A051900's PE Ratio?
PE Ratio43x
Earnings₩125.15b
Market Cap₩5.19t

Price to Earnings Ratio vs Peers

How does A051900's PE Ratio compare to its peers?

The above table shows the PE ratio for A051900 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average15.3x
A090430 Amorepacific
11.6x-21.7%₩6.8t
A002790 AMOREPACIFIC Group
7.8x2.8%₩1.8t
A192820 Cosmax
20.1x27.3%₩1.5t
A278470 APR
21.5x25.7%₩1.9t
A051900 LG H&H
43x25.5%₩5.2t

Price-To-Earnings vs Peers: A051900 is expensive based on its Price-To-Earnings Ratio (43x) compared to the peer average (15.3x).

Price to Earnings Ratio vs Industry

How does A051900's PE Ratio compare vs other companies in the KR Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
A900120 CXI Healthcare Technology Group
0.8xn/aUS$16.21m
No more companies available in this PE range
A051900 43.0xIndustry Avg. 17.3xNo. of Companies6PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: A051900 is expensive based on its Price-To-Earnings Ratio (43x) compared to the KR Personal Products industry average (17.3x).

Price to Earnings Ratio vs Fair Ratio

What is A051900's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A051900 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio43x
Fair PE Ratio22.6x

Price-To-Earnings vs Fair Ratio: A051900 is expensive based on its Price-To-Earnings Ratio (43x) compared to the estimated Fair Price-To-Earnings Ratio (22.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A051900 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩321,500.00
₩392,074.07
+22.0%
14.2%₩500,000.00₩300,000.00n/a27
Nov ’25₩332,000.00
₩392,518.52
+18.2%
14.1%₩500,000.00₩300,000.00n/a27
Oct ’25₩379,000.00
₩423,045.45
+11.6%
11.0%₩500,000.00₩330,000.00n/a22
Sep ’25₩354,500.00
₩424,652.17
+19.8%
11.0%₩500,000.00₩330,000.00n/a23
Aug ’25₩350,000.00
₩425,347.83
+21.5%
10.7%₩500,000.00₩330,000.00n/a23
Jul ’25₩361,500.00
₩432,913.04
+19.8%
10.8%₩501,000.00₩330,000.00n/a23
Jun ’25₩417,500.00
₩424,826.09
+1.8%
11.7%₩500,000.00₩315,000.00n/a23
May ’25₩420,000.00
₩416,043.48
-0.9%
13.3%₩500,000.00₩313,000.00n/a23
Apr ’25₩405,000.00
₩357,000.00
-11.9%
14.8%₩470,000.00₩250,000.00n/a23
Mar ’25₩319,000.00
₩344,826.09
+8.1%
13.5%₩440,000.00₩250,000.00n/a23
Feb ’25₩305,500.00
₩348,304.35
+14.0%
13.7%₩440,000.00₩250,000.00n/a23
Jan ’25₩355,000.00
₩431,863.64
+21.7%
20.6%₩630,000.00₩310,000.00n/a22
Dec ’24₩328,000.00
₩449,136.36
+36.9%
22.5%₩680,000.00₩330,000.00n/a22
Nov ’24₩322,500.00
₩453,857.14
+40.7%
22.3%₩680,000.00₩330,000.00₩332,000.0021
Oct ’24₩446,500.00
₩604,465.00
+35.4%
14.6%₩800,000.00₩500,000.00₩379,000.0020
Sep ’24₩484,500.00
₩622,481.82
+28.5%
17.3%₩900,000.00₩500,000.00₩354,500.0022
Aug ’24₩441,000.00
₩610,209.09
+38.4%
19.0%₩900,000.00₩420,000.00₩350,000.0022
Jul ’24₩459,000.00
₩709,818.18
+54.6%
17.0%₩946,000.00₩490,000.00₩361,500.0022
Jun ’24₩536,000.00
₩727,545.45
+35.7%
15.7%₩946,000.00₩490,000.00₩417,500.0022
May ’24₩623,000.00
₩734,095.24
+17.8%
15.4%₩946,000.00₩520,000.00₩420,000.0021
Apr ’24₩600,000.00
₩777,150.00
+29.5%
15.8%₩987,000.00₩540,000.00₩405,000.0020
Mar ’24₩668,000.00
₩794,150.00
+18.9%
14.3%₩987,000.00₩560,000.00₩319,000.0020
Feb ’24₩691,000.00
₩804,428.57
+16.4%
14.6%₩987,000.00₩560,000.00₩305,500.0021
Jan ’24₩722,000.00
₩721,428.57
-0.08%
17.1%₩950,000.00₩500,000.00₩355,000.0021
Dec ’23₩646,000.00
₩713,636.36
+10.5%
18.2%₩950,000.00₩500,000.00₩328,000.0022
Nov ’23₩526,000.00
₩713,809.52
+35.7%
18.5%₩950,000.00₩500,000.00₩322,500.0021

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

NeoPharm

₩193.5b

Engages in the manufacturing and sale of skin care products in South Korea.

A092730

₩11,840.00

7D

-9.1%

1Y

3.0%

NOVAREXLtd

₩136.0b

Manufactures, wholesales, and retails health and functional foods in South Korea and internationally.

A194700

₩7,650.00

7D

-18.7%

1Y

-31.5%

Cosmecca Korea

₩600.2b

Engages in the research and development, manufacture, and sale of skincare products in South Korea and internationally.

A241710

₩53,900.00

7D

-13.6%

1Y

44.3%